Researcher
Armand Van Deun
- Keywords:B230-bacteriology, B680-public-health, B725-diagnostics, B726-clinical-biology
- Disciplines:Bacteriology
Affiliations
- Mycobacteriology (Research unit)
Member
From1 Jan 1999 → 30 Nov 2018 - Mycobacteriology (Research unit)
Member
From1 Jan 1999 → 16 Apr 2015
Projects
1 - 4 of 4
- Novel High-Dose Tuberculosis Retreatment Regimens: How to overcome resistance without creating more?From1 Oct 2018 → 30 Sep 2024
- Significance of initial isoniazid resistance for outcome of standard TB treatment and its detection by line-probe assaysFrom1 Jan 2018 → 31 Dec 2018
- Trend of fluoroquinolone resistance among the MDR in DF BangladeshFrom1 Jan 2017 → 31 Dec 2018
- Validity and feasability of use of a rapid and innovative test for detection of Multi Drug Resistant (MDR) TB cases in Kinshasa, DRCFrom1 Mar 2009 → 6 Jul 2018
Publications
1 - 10 of 143
- Safety of high-dose amikacin in the first week of all-oral rifampicin-resistant tuberculosis treatment for the prevention of acquired resistance (STAKE): protocol for a single-arm clinical trial(2024)
Authors: Jihad Snobre, J Gasana, Jean Claude Semuto Ngabonziza, Isabel Cuella Martin, Leen Rigouts, Bart K Jacobs, Emeline de Viron, Natacha Herssens, JB Ntihumby, A Klibazayre, et al.
- Borderline rpoB mutations transmit at the same rate as common rpoB mutations in a tuberculosis cohort in Bangladesh(2023)
Authors: Pauline Lempens, Armand Van Deun, Kya J M Aung, Mohammad A Hossain, Mahboobeh Behruznia, Tom Decroo, Leen Rigouts, Bouke de Jong, Conor Meehan
- High rate of adverse drug reactions with a novel tuberculosis retreatment regimen combining triple-doses of both isoniazid and rifampicin(2023)
Authors: Mahamadou Bassirou Souleymane, Sani Kadri, Alberto Piubello, Achilleas Tsoumanis, Alphazazi Soumana, Hamidou Issa, Abdoulaziz Kabirou Amoussa, Armand Van Deun, Lut Lynen, Bouke de Jong, et al.
Pages: 78-81 - GeneXpert MTB/RIF Ultra performance to detect uncommon rpoB mutations in Mycobacterium tuberculosis(2023)
Authors: Leen Rigouts, Jelle Keysers, Rabab Reenaers, Kristina Fissette, Armand Van Deun, Bouke de Jong
- Definitive outcomes in patients with rifampicin-resistant tuberculosis treated in Niger from 2012 to 2019: a retrospective cohort study(2023)
Authors: Mahamadou Bassirou Souleymane, Tom Decroo, Saïdou Mamadou, Alphazazi Soumana, Ibrahim Mamane Lawan, Assiatou Gagara-Issoufou, Eric Adehossi, Nimer Ortuño-Gutiérrez, Lut Lynen, Leen Rigouts, et al.
Pages: 258–264 - Failure or relapse predictors for the STREAM Stage 1 short regimen for RR-TB(2022)
Authors: D. M. Kokebu, S. Ahmed, R. Moodliar, C.Y. Chiang, Gabriela Torrea, Armand Van Deun, Ruth L. Goodall, I. D. Rusen, S. K. Meredith, A J Nunn
Pages: 753-759 - Safety, effectiveness, and adherence of a short and all-oral treatment regimen for the treatment of rifampicin-resistant tuberculosis in Niger: a study protocol of a pragmatic randomised clinical trial with stratified block randomisation(2022)
Authors: Mahamadou Bassirou Souleymane, Tom Decroo, Alphazazi Soumana, Ibrahim Maman Lawan, Assiatou Gagara-Issoufou, Souleymane Halidou-Moussa, Nimer Ortuno-Gutierrez, Eric Adehossi, Saidou Mamadou, Armand Van Deun, et al.
- Acquired rifampicin resistance during first TB treatment: magnitude, relative importance, risk factors and keys to control in low-income settings(2022)
Authors: Armand Van Deun, Valentin Bola, Rossin Lebeke, Michel Kayomo Kaswa, Mohamed Anwar Hossain, Mourad Gumusboga, Gabriela Torrea, Bouke de Jong, Leen Rigouts, Tom Decroo
- Pretomanid for tuberculosis: a systematic review(2022)
Authors: Tinne Gils, Lut Lynen, Bouke de Jong, Armand Van Deun, Tom Decroo
Pages: 31-42 - Implications of bedaquiline-resistant tuberculosis(2022)
Authors: Tom Decroo, Armand Van Deun
Pages: 166-167